SPINE
CDR and ACDF similarly cost-effective in the treatment of DDD
This report has been verified
by one or more authors of the
original publication.
J Neurosurg Spine. 2014 May;20(5):475-9
209 patients with cervical radiculopathy due to single level cervical degenerative disc disease (DDD) were randomized to undergo cervical arthroplasty (CDR) or anterior cervical discectomy and fusion (ACDF) in a previous investigational device exemption (IDE) trial. A cost-effectiveness analysis (CEA) was performed on data from the previous trial to discern the most cost-efficient treatment for cervical DDD. Cost effectiveness was based on Short-Form 36 (SF-36) data collected from the original trial. Health State Utility was calculated based on SF-36 data collected over 2 years. The evidence presented in this study demonstrated that both cervical arthroplasty (CDR) and anterior cervical discectomy and fusion (ACDF) incurred comparable costs in the treatment of degenerative disc disease.
Unlock the full ACE Report
You have access to {0} free articles per month.Click below to unlock and view this {1}
Unlock NowCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidence content for just $1.99 per week.
Already have an account? Log in
Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.
{0} of {1} free articles
Become an OrthoEvidence Premium Member. Expand your perspective with high-quality evidence.
Upgrade Now
